4DMT Presents Positive Interim Data from Aerosolized 4D-710
Reported data from cohort 1 (n=3, 1E15 vg dose) of cystic fibrosis modulator treatment ineligible/intolerant participants with 9-12 months follow-up ...
Source: globenewswire.com
Page 10 - Cf Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cf Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cf Foundation Today - Breaking & Trending Today
Stock Market | FinancialContent Business Page
FinancialContent fully hosted finance channel
Source: financialcontent.com
4DMT Presents Positive Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial in Patients with Cystic Fibrosis at the ECFS 46th Annual Meeting
Reported data from cohort 1 of cystic fibrosis modulator treatment ineligible/intolerant participants with 9-12 months follow-up Quality of life outcomes measured by Cystic... | June 9, 2023
Source: marketscreener.com
No benefit in adding hypertonic saline to Pulmozyme for CF: Study | Combined CF treatment not found to improve patients' lung function
No differences in lung function were seen for CF patients given Pulmozyme treatment plus hypertonic saline versus the approved therapy alone.
Source: cysticfibrosisnewstoday.com
4DMT to Present Interim Data from 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis Lung Disease at the European Cystic Fibrosis Society (ECFS) 46th Annual Meeting
Interim data to be presented in an oral presentation by Dr. Jennifer L. Taylor-Cousar, MD, MSCS at the 2023 ECFS Annual Meeting in Vienna, Austria on Thursday, June 8, 2023 at 5:00 p.m. CET Company to... | May 24, 2023
Source: marketscreener.com